Efficacy of Combination Immunotherapy in Patients With Metastatic Colorectal Cancer

NCT05414461 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

97

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer

Interventions

DRUG: Combinations

Sponsor

First Affiliated Hospital of Zhejiang University